Education
About Us
Working with TipRanks
Follow Us
Syncom Formulation (India) Ltd. (IN:SYNCOMF)
:SYNCOMF
SYNCOMF Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹11.00 - ₹27.94
Previous CloseN/A
Volume2.15M
Average Volume (3M)896.34K
Market Cap
₹20.50B
Enterprise ValueN/A
Total Cash (Recent Filing)₹1.32B
Total Debt (Recent Filing)₹724.87M
Price to Earnings (P/E)42.6
Beta1.40
Next Earnings
Aug 18, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 09, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)0.16
Shares Outstanding940,000,000
10 Day Avg. Volume1,779,659
30 Day Avg. Volume896,340
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
SYNCOMF FAQ
What was Syncom Formulation (India) Ltd.’s price range in the past 12 months?
Syncom Formulation (India) Ltd. lowest stock price was ₹11.00 and its highest was ₹27.94 in the past 12 months.
What is Syncom Formulation (India) Ltd.’s market cap?
Syncom Formulation (India) Ltd.’s market cap is ₹20.50B.
When is Syncom Formulation (India) Ltd.’s upcoming earnings report date?
Syncom Formulation (India) Ltd.’s upcoming earnings report date is Aug 18, 2025 which is in 74 days.
How were Syncom Formulation (India) Ltd.’s earnings last quarter?
Syncom Formulation (India) Ltd. released its earnings results on May 19, 2025. The company reported ₹0.16 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.16.
Is Syncom Formulation (India) Ltd. overvalued?
According to Wall Street analysts Syncom Formulation (India) Ltd.’s price is currently Overvalued.
Does Syncom Formulation (India) Ltd. pay dividends?
Syncom Formulation (India) Ltd. pays a Notavailable dividend of ₹0.029 which represents an annual dividend yield of N/A. See more information on Syncom Formulation (India) Ltd. dividends here
What is Syncom Formulation (India) Ltd.’s EPS estimate?
Syncom Formulation (India) Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Syncom Formulation (India) Ltd. have?
Syncom Formulation (India) Ltd. has 940,000,000 shares outstanding.
What happened to Syncom Formulation (India) Ltd.’s price movement after its last earnings report?
Syncom Formulation (India) Ltd. reported an EPS of ₹0.16 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 8.11%.
Which hedge fund is a major shareholder of Syncom Formulation (India) Ltd.?
Currently, no hedge funds are holding shares in IN:SYNCOMF
Technical Analysis
Aarti Drugs Limited
―
Jaypee Infratech Limited
―
Lincoln Pharmaceuticals Ltd
―
Shilpa Medicare Limited
―
SMS Pharmaceuticals Limited
―